South San Francisco, CA, United States of America

Parthasarathy Sampathkumar


Average Co-Inventor Count = 5.8

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2023-2024

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Parthasarathy Sampathkumar: Innovator in Therapeutic Antibodies

Introduction

Parthasarathy Sampathkumar is a notable inventor based in South San Francisco, CA. He has made significant contributions to the field of therapeutic antibodies, holding 2 patents that focus on innovative treatments for various diseases. His work is characterized by a commitment to advancing medical science through targeted therapies.

Latest Patents

Sampathkumar's latest patents include "Anti-frizzled antibodies and methods of use" and "Anti-LRP5/6 antibodies and methods of use." The first patent provides anti-Fzd monoclonal antibodies and related compositions, which may be utilized in a variety of therapeutic methods for treating diseases. The second patent offers anti-LRP5/6 monoclonal antibodies and related compositions, aimed at addressing diseases and disorders associated with Wnt pathway signaling.

Career Highlights

Parthasarathy Sampathkumar is currently associated with Surrozen Operating, Inc., where he continues to develop groundbreaking therapeutic solutions. His work has positioned him as a key figure in the biotechnology sector, contributing to advancements that have the potential to improve patient outcomes.

Collaborations

Sampathkumar collaborates with talented individuals such as Yang Li and Tom Zhiye Yuan, enhancing the innovative capacity of his projects. These collaborations reflect a strong team dynamic focused on achieving significant breakthroughs in therapeutic applications.

Conclusion

Parthasarathy Sampathkumar's contributions to the field of therapeutic antibodies exemplify the impact of innovation in medicine. His patents and ongoing work at Surrozen Operating, Inc. highlight his dedication to improving healthcare through scientific advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…